Your browser doesn't support javascript.
loading
Acute and sub acute toxicity of Amirdha Gandhi Kukkil Vallathy an effective Siddha herbo mineral formulation used in the treatment of rheumatoid arthritis in wistar albino rat model.
Lawrence, Juliet; Jabaris S, Sugin Lal; Bhogireddy, Ramadevi; Kadarkarai, Kanakavalli; Natarajan, Kabilan; Jhonson, Christian Gnanaraj; Rathinam, Ganesan; Sandhirappan, Sivakkumar.
Afiliação
  • Lawrence J; Department of Clinical Research, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of Ayush, Government of India, Chennai, Tamil Nadu, India.
  • Jabaris S SL; Department of Pharmacology, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of Ayush, Government of India, Chennai, Tamil Nadu, India.
  • Bhogireddy R; Department of Pharmacology, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of Ayush, Government of India, Chennai, Tamil Nadu, India.
  • Kadarkarai K; Central Council for Research in Siddha, Ministry of Ayush, Government of India, Chennai, Tamil Nadu, India.
  • Natarajan K; Department of Siddha, The TN Dr. MGR Medical University, Chennai, Tamil Nadu, India.
  • Jhonson CG; Department of Noi Nadal, National Institute of Siddha, Ministry of Ayush, Chennai, Tamil Nadu, India.
  • Rathinam G; Department of Biochemistry, Siddha Central Research Institute, Central Council for Research in Siddha, Ministry of Ayush, Government of India, Chennai, Tamil Nadu, India.
  • Sandhirappan S; Department of Gunapadam, National Institute of Siddha, Ministry of Ayush, Chennai, Tamil Nadu, India.
J Complement Integr Med ; 20(3): 556-565, 2023 Sep 01.
Article em En | MEDLINE | ID: mdl-37300384
ABSTRACT

OBJECTIVES:

Amirdha Gandhi Kukkil Vallathy (AGKV) is a herbo mineral Siddha formulation which has Sulphur, Kukkil, Seendhil and Serankottai as major ingredients and it is indicated for 80 types of Vatham diseases. Uthiravatha suronitham is one among the vatham diseases and it's clinical symptoms are correlated with Rheumatoid arthritis (RA). Since AGKV is a promising drug for RA, the safety of this drug has been validated by performing the acute and 28 days repeated oral dose toxicity study following the OECD guidelines 423 and 407.

METHODS:

The acute toxicity study has been performed by administering orally with a single dose of 300 and 2000 mg/kg body weight in rat models and the animals were observed for 14 consecutive days. Gross pathology was observed and animals were sacrificed at the end of the study. In 28 days repeated oral toxicity study, limit test has been carried out with a dose of 1,000 mg/kg body weight.

RESULTS:

No significant abnormality has been observed in the body weight, organ weight, biochemical parameters and histopathology studies. It has been revealed that this drug is safe upto 2000 mg/kg body weight in single dose study and 1,000 mg is a safer dose in the 28 days repeated oral toxicity study.

CONCLUSIONS:

The results of acute and 28 days repeated oral toxicity studies revealed no adverse effects in animals and hence this drug AGKV is safe and can be administered in human.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article